0 Parkinson’s disease: spinal stimulation restores movement
People who were previously housebound with Parkinson’s disease are now able to walk more freely thanks to spinal stimulation treatment.
Browsing: Movement disorders
0 World Parkinson’s Day 2019 – a note from the Editor
To mark World Parkinson’s Day, we’re taking the opportunity to look back on some of the research highlights in the field over the last year.
0 Dogs can detect epileptic seizure odor, study indicates
A recently published study has provided evidence that could potentially aid reports into dogs detecting an epileptic seizure odor.
0 Groundbreaking Parkinson’s trial offers hope for restoring damaged brain cells
A groundbreaking treatment that delivers a drug directly to the brain may offer hope to restore damaged brain cells in Parkinson’s disease.
0 Wireless ‘pacemaker for the brain’ could treat tremors and seizures in neurological diseases
Researchers have developed a ‘pacemaker for the brain’, which can monitor and stimulate electric currents, potentially leading to novel treatments in individuals with neurological diseases.
0 RESTORE-1: first patient dosed with gene therapy in Parkinson’s trial
Voyager Therapeutics has announced the first patient dosed in RESTORE-1, a Phase II trial of VY-AADC gene therapy for the treatment of Parkinson’s disease.
0 BrainStorm scraps initial access to NurOwn® for amyotrophic lateral sclerosis
After careful evaluation of the ‘Right to Try ‘Act, BrainStorm have announced that it will not make NurOwn® available under this legislation at this time.
0 Parkinson’s drugs may cause impulse control disorders
Dopamine agonists and prodrugs taken to treat Parkinson’s disease may cause impulse control disorders in over half the patients they are prescribed to.
0 Is there a link between diabetes and Parkinson’s disease?
According to a large study, individuals with Type 2 diabetes may have an increased risk of being diagnosed with Parkinson’s disease later in life.
0 Multiple sclerosis: new UK guidelines on disease-modifying therapies
The National Institute for Health and Care Excellence (NICE) has recommended the use of four out of six disease-modifying therapies in relapsing–remitting multiple sclerosis.
